DOCSLIB.ORG

Supplementary Table 6: Hypothalamic ARC Microarray Fold Changes Between DR and Chow Mice

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Table 6: Hypothalamic ARC Microarray Fold Changes Between DR and Chow Mice Supplementary Table 6: Hypothalamic ARC microarray fold changes between DR and Chow mice. Genes increased in DR compared to Chow (in order of fold change) Fold Gene Gene name change P-value Cga glycoprotein hormones, alpha subunit 2.629 0.017 BC038167 1.734 0.019 Gng2 guanine nucleotide binding protein (G protein), gamma 2 1.596 0.007 Ecel1 endothelin converting enzyme-like 1 1.577 0.024 Inmt indolethylamine N-methyltransferase 1.572 0.047 Rsph1 radial spoke head 1 homolog (Chlamydomonas) 1.544 0.015 Npffr1 PREDICTED: neuropeptide FF receptor 1 1.536 0.019 Apoc3 apolipoprotein C-III 1.502 0.023 Mrpl9 mitochondrial ribosomal protein L9 1.500 0.042 Genes decreased in DR compared to Chow (in order of fold change) Ankrd11 ankyrin repeat domain 11 -2.826 0.003 Pkp4 plakophilin 4 (Pkp4) -2.50978 0.009 B230209E15Rik PREDICTED: RIKEN cDNA B230209E15 gene -2.25316 0.007 Eif5 eukaryotic translation initiation factor 5 -2.15052 0.040 Gcap14 granule cell antiserum positive 14 -2.14545 0.016 Cplx2 complexin 2 -2.12784 0.019 eukaryotic translation initiation factor 4E binding protein Eif4ebp2 2 -2.1111 0.008 scl0002315.1_12 -2.10515 0.022 Sept03 septin 3 -2.08598 0.044 4921506J03Rik -2.03777 0.012 5730455P16Rik RIKEN cDNA 5730455P16 gene -1.9862 0.028 3300001P08Rik RIKEN cDNA 3300001P08 gene -1.98069 0.031 6430548M08Rik -1.97259 0.021 Peg3 paternally expressed 3 -1.96637 0.008 Atxn1 ataxin 1 -1.96061 0.019 Lin7a lin-7 homolog A (C. elegans) -1.95696 0.015 Scn1a -1.90695 0.028 Zmat1 zinc finger, matrin type 1 -1.90296 0.008 Tbl1x transducin (beta)-like 1 X-linked -1.90109 0.006 Cntn2 contactin 2 -1.89999 0.014 Zeb2 zinc finger E-box binding homeobox 2 -1.89491 0.009 Impad1 inositol monophosphatase domain containing 1 -1.88478 0.008 Csnk2a1-rs3 -1.86782 0.020 Rgs7bp regulator of G-protein signalling 7 binding protein -1.85758 0.009 DNA segment, Chr 11, Brigham & Women's Genetics 0517 D11Bwg0517e expressed -1.83038 0.025 ELAV (embryonic lethal, abnormal vision, Drosophila)-like Elavl3 3 (Hu antigen C) -1.81927 0.0009 Osbpl1a oxysterol binding protein-like 1A -1.81829 0.0040 N-ethylmaleimide sensitive fusion protein attachment Napb protein beta -1.80157 0.018 Clic4 chloride intracellular channel 4 (mitochondrial) -1.78587 0.002 Limch1 LIM and calponin homology domains 1 -1.77659 0.003 Fbxo41 F-box protein 41 -1.77105 0.004 Hist1h2ak histone cluster 1, H2ak -1.75258 0.029 Myoc myocilin -1.75234 0.006 Ddx6 DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 -1.74423 0.014 Mtap9 microtubule-associated protein 9. -1.73725 0.008 Alcam activated leukocyte cell adhesion molecule -1.73406 0.036 B930006L02Rik -1.73299 0.002 C030033M19Rik -1.72995 0.010 Fam168a family with sequence similarity 168, member A -1.72689 0.003 Pabpc1 poly A binding protein, cytoplasmic 1 -1.72379 0.001 1110001C20Rik -1.7224 0.019 Nrp1 neuropilin 1 -1.71975 0.014 Klf7 Kruppel-like factor 7 (ubiquitous) -1.70925 0.032 Pcdh9 protocadherin 9 -1.70637 0.012 BC042720 PREDICTED: cDNA sequence BC042720 -1.70327 0.004 Susd4 sushi domain containing 4 -1.70091 0.023 Fbxl11 F-box and leucine-rich repeat protein 11 -1.69822 0.010 Ankrd12 ankyrin repeat domain 12 -1.68516 0.006 Fam134b family with sequence similarity 134, member B -1.67611 0.029 Scn3a sodium channel, voltage-gated, type III, alpha -1.67477 0.022 Mboat2 membrane bound O-acyltransferase domain containing 2 -1.67127 0.020 Mpv17 Mpv17 transgene, kidney disease mutant -1.67012 0.019 Arid4a AT rich interactive domain 4A (RBP1-like) -1.66886 0.016 Cygb cytoglobin -1.66305 0.029 DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X- Ddx3x linked -1.65898 0.010 Mapk8ip2 -1.65183 0.007 Synm synemin, intermediate filament protein -1.65168 0.011 Nfic nuclear factor I/C -1.63259 0.020 Csnk1e casein kinase 1, epsilon -1.60503 0.048 proteasome (prosome, macropain) 26S subunit, non- Psmd1 ATPase, 1 -1.60227 0.008 LOC671878 PREDICTED: similar to spermine synthase -1.60084 0.021 PREDICTED: similar to neurotrophic tyrosine kinase, LOC100047606 receptor, type 3 -1.60083 0.011 Dusp1 dual specificity phosphatase 1 -1.59973 0.011 Map3k1 mitogen-activated protein kinase kinase kinase 1 -1.59181 0.004 Zfp326 zinc finger protein 326 -1.59108 0.013 Odz2 odd Oz/ten-m homolog 2 (Drosophila) -1.58915 0.013 A930010C08Rik -1.58678 0.026 C130072A16Rik -1.58537 0.009 Cnnm1 cyclin M1 -1.57887 0.011 Hnt neurotrimin -1.57729 0.014 Zc3h13 zinc finger CCCH type containing 13 -1.57357 0.004 D030034I04Rik -1.56794 0.026 Brunol4 bruno-like 4, RNA binding protein (Drosophila) -1.56604 0.045 Aqp4 aquaporin 4 -1.56564 0.039 Unc13c unc-13 homolog C (C. elegans) -1.56237 0.017 Nr4a2 nuclear receptor subfamily 4, group A, member 2 -1.56084 0.025 Keap1 kelch-like ECH-associated protein 1 -1.5581 0.011 scl0001493.1_2 -1.55692 0.041 Dpysl3 dihydropyrimidinase-like 3 -1.55663 0.020 Exoc4 exocyst complex component 4 -1.55518 0.049 Dnajc5 DnaJ (Hsp40) homolog, subfamily C, member 5 -1.54355 0.029 Sfrs15 splicing factor, arginine/serine-rich 15 -1.54271 0.0008 Pcyt1a phosphate cytidylyltransferase 1, choline, alpha isoform -1.54127 0.012 Rnf6 ring finger protein (C3H2C3 type) 6 -1.53589 0.010 Tshz1 teashirt zinc finger family member 1 -1.5351 0.013 Pdap1 PDGFA associated protein 1 -1.53417 0.010 PREDICTED: similar to Limb expression 1 homolog LOC100045869 (chicken) -1.53324 0.003 protein tyrosine phosphatase, receptor type Z, Ptprz1 polypeptide 1 -1.53222 0.001 peroxisome proliferative activated receptor, gamma, Ppargc1a coactivator 1 alpha -1.52998 0.014 2900083I11Rik -1.52907 0.003 4732418C07Rik RIKEN cDNA 4732418C07 gene -1.52385 0.017 E430005I09Rik -1.52259 0.016 Gnaq guanine nucleotide binding protein, alpha q polypeptide -1.52151 0.035 Zswim6 -1.52027 0.039 2600009P04Rik -1.51949 0.011 Dusp7 dual specificity phosphatase 7 -1.51903 0.006 Sel1l sel-1 suppressor of lin-12-like (C. elegans) -1.51711 0.014 4732462B05Rik -1.51482 0.016 C030011O14Rik -1.50903 0.013 Elfn2 leucine rich repeat and fibronectin type III, extracellular 2 -1.50901 0.048 Ddx26 -1.50695 4.04E-06 PREDICTED: Mus zinc finger protein 292, transcript Zfp292 variant 4 -1.50451 0.022 C130078N17Rik -1.50225 0.005 .
Load more

Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Related Malignant Phenotypes in the Nf1-Deficient MPNST
    Published OnlineFirst February 19, 2013; DOI: 10.1158/1541-7786.MCR-12-0593 Molecular Cancer Genomics Research RAS/MEK–Independent Gene Expression Reveals BMP2- Related Malignant Phenotypes in the Nf1-Deficient MPNST Daochun Sun1, Ramsi Haddad2,3, Janice M. Kraniak2, Steven D. Horne1, and Michael A. Tainsky1,2 Abstract Malignant peripheral nerve sheath tumor (MPNST) is a type of soft tissue sarcoma that occurs in carriers of germline mutations in Nf1 gene as well as sporadically. Neurofibromin, encoded by the Nf1 gene, functions as a GTPase-activating protein (GAP) whose mutation leads to activation of wt-RAS and mitogen-activated protein kinase (MAPK) signaling in neurofibromatosis type I (NF1) patients' tumors. However, therapeutic targeting of RAS and MAPK have had limited success in this disease. In this study, we modulated NRAS, mitogen-activated protein/extracellular signal–regulated kinase (MEK)1/2, and neurofibromin levels in MPNST cells and determined gene expression changes to evaluate the regulation of signaling pathways in MPNST cells. Gene expression changes due to neurofibromin modulation but independent of NRAS and MEK1/2 regulation in MPNST cells indicated bone morphogenetic protein 2 (Bmp2) signaling as a key pathway. The BMP2-SMAD1/5/8 pathway was activated in NF1-associated MPNST cells and inhibition of BMP2 signaling by LDN-193189 or short hairpin RNA (shRNA) to BMP2 decreased the motility and invasion of NF1-associated MPNST cells. The pathway-specific gene changes provide a greater understanding of the complex role of neurofibromin in MPNST pathology and novel targets for drug discovery. Mol Cancer Res; 11(6); 616–27.
    [Show full text]
  • Transcriptomic Analysis of Native Versus Cultured Human and Mouse Dorsal Root Ganglia Focused on Pharmacological Targets Short
    bioRxiv preprint doi: https://doi.org/10.1101/766865; this version posted September 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Transcriptomic analysis of native versus cultured human and mouse dorsal root ganglia focused on pharmacological targets Short title: Comparative transcriptomics of acutely dissected versus cultured DRGs Andi Wangzhou1, Lisa A. McIlvried2, Candler Paige1, Paulino Barragan-Iglesias1, Carolyn A. Guzman1, Gregory Dussor1, Pradipta R. Ray1,#, Robert W. Gereau IV2, # and Theodore J. Price1, # 1The University of Texas at Dallas, School of Behavioral and Brain Sciences and Center for Advanced Pain Studies, 800 W Campbell Rd. Richardson, TX, 75080, USA 2Washington University Pain Center and Department of Anesthesiology, Washington University School of Medicine # corresponding authors [email protected], [email protected] and [email protected] Funding: NIH grants T32DA007261 (LM); NS065926 and NS102161 (TJP); NS106953 and NS042595 (RWG). The authors declare no conflicts of interest Author Contributions Conceived of the Project: PRR, RWG IV and TJP Performed Experiments: AW, LAM, CP, PB-I Supervised Experiments: GD, RWG IV, TJP Analyzed Data: AW, LAM, CP, CAG, PRR Supervised Bioinformatics Analysis: PRR Drew Figures: AW, PRR Wrote and Edited Manuscript: AW, LAM, CP, GD, PRR, RWG IV, TJP All authors approved the final version of the manuscript. 1 bioRxiv preprint doi: https://doi.org/10.1101/766865; this version posted September 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Investigation of Candidate Genes and Mechanisms Underlying Obesity
    Prashanth et al. BMC Endocrine Disorders (2021) 21:80 https://doi.org/10.1186/s12902-021-00718-5 RESEARCH ARTICLE Open Access Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules G. Prashanth1 , Basavaraj Vastrad2 , Anandkumar Tengli3 , Chanabasayya Vastrad4* and Iranna Kotturshetti5 Abstract Background: Obesity associated type 2 diabetes mellitus is a metabolic disorder ; however, the etiology of obesity associated type 2 diabetes mellitus remains largely unknown. There is an urgent need to further broaden the understanding of the molecular mechanism associated in obesity associated type 2 diabetes mellitus. Methods: To screen the differentially expressed genes (DEGs) that might play essential roles in obesity associated type 2 diabetes mellitus, the publicly available expression profiling by high throughput sequencing data (GSE143319) was downloaded and screened for DEGs. Then, Gene Ontology (GO) and REACTOME pathway enrichment analysis were performed. The protein - protein interaction network, miRNA - target genes regulatory network and TF-target gene regulatory network were constructed and analyzed for identification of hub and target genes. The hub genes were validated by receiver operating characteristic (ROC) curve analysis and RT- PCR analysis. Finally, a molecular docking study was performed on over expressed proteins to predict the target small drug molecules. Results: A total of 820 DEGs were identified between
    [Show full text]
  • Expression Profiling of Ion Channel Genes Predicts Clinical Outcome in Breast Cancer
    UCSF UC San Francisco Previously Published Works Title Expression profiling of ion channel genes predicts clinical outcome in breast cancer Permalink https://escholarship.org/uc/item/1zq9j4nw Journal Molecular Cancer, 12(1) ISSN 1476-4598 Authors Ko, Jae-Hong Ko, Eun A Gu, Wanjun et al. Publication Date 2013-09-22 DOI http://dx.doi.org/10.1186/1476-4598-12-106 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Ko et al. Molecular Cancer 2013, 12:106 http://www.molecular-cancer.com/content/12/1/106 RESEARCH Open Access Expression profiling of ion channel genes predicts clinical outcome in breast cancer Jae-Hong Ko1, Eun A Ko2, Wanjun Gu3, Inja Lim1, Hyoweon Bang1* and Tong Zhou4,5* Abstract Background: Ion channels play a critical role in a wide variety of biological processes, including the development of human cancer. However, the overall impact of ion channels on tumorigenicity in breast cancer remains controversial. Methods: We conduct microarray meta-analysis on 280 ion channel genes. We identify candidate ion channels that are implicated in breast cancer based on gene expression profiling. We test the relationship between the expression of ion channel genes and p53 mutation status, ER status, and histological tumor grade in the discovery cohort. A molecular signature consisting of ion channel genes (IC30) is identified by Spearman’s rank correlation test conducted between tumor grade and gene expression. A risk scoring system is developed based on IC30. We test the prognostic power of IC30 in the discovery and seven validation cohorts by both Cox proportional hazard regression and log-rank test.
    [Show full text]
  • Pleiotrophin Regulates the Ductular Reaction by Controlling the Migration
    Gut Online First, published on March 10, 2015 as 10.1136/gutjnl-2014-308176 Hepatology ORIGINAL ARTICLE Gut: first published as 10.1136/gutjnl-2014-308176 on 16 January 2015. Downloaded from Pleiotrophin regulates the ductular reaction by controlling the migration of cells in liver progenitor niches Gregory A Michelotti,1 Anikia Tucker,1 Marzena Swiderska-Syn,1 Mariana Verdelho Machado,1 Steve S Choi,1,2 Leandi Kruger,1 Erik Soderblom,3 J Will Thompson,3 Meredith Mayer-Salman,3 Heather A Himburg,4 Cynthia A Moylan,1,2 Cynthia D Guy,5 Katherine S Garman,1,2 Richard T Premont,1 John P Chute,4 Anna Mae Diehl1 ▸ Additional material is ABSTRACT published online only. To view Objective The ductular reaction (DR) involves Significance of this study please visit the journal online (http://dx.doi.org/10.1136/ mobilisation of reactive-appearing duct-like cells (RDC) gutjnl-2014-308176). along canals of Hering, and myofibroblastic (MF) differentiation of hepatic stellate cells (HSC) in the space 1Division of Gastroenterology, What is already known about this subject? Duke University, Durham, of Disse. Perivascular cells in stem cell niches produce ▸ Various types of liver injury promote a ductular North Carolina, USA pleiotrophin (PTN) to inactivate the PTN receptor, protein reaction (DR) characterised by the periportal 2Section of Gastroenterology, tyrosine phosphatase receptor zeta-1 (PTPRZ1), thereby accumulation of small ductules, myofibroblasts Durham Veterans Affairs augmenting phosphoprotein-dependent signalling. We and collagen matrix. Medical Center, Durham, ▸ Pleiotrophin (PTN) is a heparin-binding growth North Carolina, USA hypothesised that the DR is regulated by PTN/PTPRZ1 3Proteomics Center, signalling.
    [Show full text]
  • Transmembrane Protein with Unknown Function 16A Overexpression Promotes Glioma Formation Through the Nuclear Factor‑Κb Signaling Pathway
    1068 MOLECULAR MEDICINE REPORTS 9: 1068-1074, 2014 Transmembrane protein with unknown function 16A overexpression promotes glioma formation through the nuclear factor‑κB signaling pathway JUN LIU1, YU LIU2, YINGANG REN1, LI KANG1 and LIHUA ZHANG1 Departments of 1Geriatrics and 2Neurology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China Received July 18, 2013; Accepted January 2, 2014 DOI: 10.3892/mmr.2014.1888 Abstract. Ion channels have been suggested to be important in Introduction the development and progression of tumors, however, chloride channels have rarely been analyzed in tumorigenesis. More In previous years, the association between ion channels and recently, transmembrane protein with unknown function 16A tumors has drawn particular attention. Increasing evidence has (TMEM16A), hypothesized to be a candidate calcium-acti- demonstrated that ion channels are involved in the regulation vated Cl- channel, has been found to be overexpressed in a of tumor progression, including potassium (1-3), calcium (4) number of tumor types. Although several studies have impli- and sodium channels (5,6). Therefore, understanding the cated the overexpression of TMEM16A in certain tumor types, underlying molecular mechanisms of ion channels in tumori- the exact role of TMEM16A in gliomas and the underlying genesis, and tumor progression and migration provides novel mechanisms in tumorigenesis, remain poorly understood. In insights into tumor pathogenesis, and also identifies potential the present study, the role of TMEM16A in gliomas and the targets for tumor prevention and treatment. potential underlying mechanisms were analyzed. TMEM16A Chloride channels are expressed ubiquitously and are was highly abundant in various grades of gliomas and important in various cellular processes, including the cell cycle cultured glioma cells.
    [Show full text]
  • 140503 IPF Signatures Supplement Withfigs Thorax
    Supplementary material for Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis Daryle J. DePianto1*, Sanjay Chandriani1⌘*, Alexander R. Abbas1, Guiquan Jia1, Elsa N. N’Diaye1, Patrick Caplazi1, Steven E. Kauder1, Sabyasachi Biswas1, Satyajit K. Karnik1#, Connie Ha1, Zora Modrusan1, Michael A. Matthay2, Jasleen Kukreja3, Harold R. Collard2, Jackson G. Egen1, Paul J. Wolters2§, and Joseph R. Arron1§ 1Genentech Research and Early Development, South San Francisco, CA 2Department of Medicine, University of California, San Francisco, CA 3Department of Surgery, University of California, San Francisco, CA ⌘Current address: Novartis Institutes for Biomedical Research, Emeryville, CA. #Current address: Gilead Sciences, Foster City, CA. *DJD and SC contributed equally to this manuscript §PJW and JRA co-directed this project Address correspondence to Paul J. Wolters, MD University of California, San Francisco Department of Medicine Box 0111 San Francisco, CA 94143-0111 [email protected] or Joseph R. Arron, MD, PhD Genentech, Inc. MS 231C 1 DNA Way South San Francisco, CA 94080 [email protected] 1 METHODS Human lung tissue samples Tissues were obtained at UCSF from clinical samples from IPF patients at the time of biopsy or lung transplantation. All patients were seen at UCSF and the diagnosis of IPF was established through multidisciplinary review of clinical, radiological, and pathological data according to criteria established by the consensus classification of the American Thoracic Society (ATS) and European Respiratory Society (ERS), Japanese Respiratory Society (JRS), and the Latin American Thoracic Association (ALAT) (ref. 5 in main text). Non-diseased normal lung tissues were procured from lungs not used by the Northern California Transplant Donor Network.
    [Show full text]
  • Macrophages/Microglia in the Glioblastoma Tumor Microenvironment
    International Journal of Molecular Sciences Review Macrophages/Microglia in the Glioblastoma Tumor Microenvironment Jun Ma, Clark C. Chen * and Ming Li * Department of Neurosurgery, University of Minnesota, Minneapolis, MN 55455, USA; [email protected] * Correspondence: [email protected] (C.C.C.); [email protected] (M.L.) Abstract: The complex interaction between glioblastoma and its microenvironment has been rec- ognized for decades. Among various immune profiles, the major population is tumor-associated macrophage, with microglia as its localized homolog. The present definition of such myeloid cells is based on a series of cell markers. These good sentinel cells experience significant changes, facilitat- ing glioblastoma development and protecting it from therapeutic treatments. Huge, complicated mechanisms are involved during the overall processes. A lot of effort has been dedicated to crack the mysterious codes in macrophage/microglia recruiting, activating, reprogramming, and functioning. We have made our path. With more and more key factors identified, a lot of new therapeutic methods could be explored to break the ominous loop, to enhance tumor sensitivity to treatments, and to improve the prognosis of glioblastoma patients. However, it might be a synergistic system rather than a series of clear, stepwise events. There are still significant challenges before the light of truth can shine onto the field. Here, we summarize recent advances in this field, reviewing the path we have been on and where we are now. Keywords: glioblastoma; tumor microenvironment; glioblastoma-associated macrophages/microglia; macrophage; microglia Citation: Ma, J.; Chen, C.C.; Li, M. Macrophages/Microglia in the Glioblastoma Tumor Int. J. Mol. Sci. Microenvironment. 1. Glioblastoma Associated Macrophages/Microglia 2021, 22, 5775.
    [Show full text]
  • 1 No. Affymetrix ID Gene Symbol Genedescription Gotermsbp Q Value 1. 209351 at KRT14 Keratin 14 Structural Constituent of Cyto
    1 Affymetrix Gene Q No. GeneDescription GOTermsBP ID Symbol value structural constituent of cytoskeleton, intermediate 1. 209351_at KRT14 keratin 14 filament, epidermis development <0.01 biological process unknown, S100 calcium binding calcium ion binding, cellular 2. 204268_at S100A2 protein A2 component unknown <0.01 regulation of progression through cell cycle, extracellular space, cytoplasm, cell proliferation, protein kinase C inhibitor activity, protein domain specific 3. 33323_r_at SFN stratifin/14-3-3σ binding <0.01 regulation of progression through cell cycle, extracellular space, cytoplasm, cell proliferation, protein kinase C inhibitor activity, protein domain specific 4. 33322_i_at SFN stratifin/14-3-3σ binding <0.01 structural constituent of cytoskeleton, intermediate 5. 201820_at KRT5 keratin 5 filament, epidermis development <0.01 structural constituent of cytoskeleton, intermediate 6. 209125_at KRT6A keratin 6A filament, ectoderm development <0.01 regulation of progression through cell cycle, extracellular space, cytoplasm, cell proliferation, protein kinase C inhibitor activity, protein domain specific 7. 209260_at SFN stratifin/14-3-3σ binding <0.01 structural constituent of cytoskeleton, intermediate 8. 213680_at KRT6B keratin 6B filament, ectoderm development <0.01 receptor activity, cytosol, integral to plasma membrane, cell surface receptor linked signal transduction, sensory perception, tumor-associated calcium visual perception, cell 9. 202286_s_at TACSTD2 signal transducer 2 proliferation, membrane <0.01 structural constituent of cytoskeleton, cytoskeleton, intermediate filament, cell-cell adherens junction, epidermis 10. 200606_at DSP desmoplakin development <0.01 lectin, galactoside- sugar binding, extracellular binding, soluble, 7 space, nucleus, apoptosis, 11. 206400_at LGALS7 (galectin 7) heterophilic cell adhesion <0.01 2 S100 calcium binding calcium ion binding, epidermis 12. 205916_at S100A7 protein A7 (psoriasin 1) development <0.01 S100 calcium binding protein A8 (calgranulin calcium ion binding, extracellular 13.
    [Show full text]
  • Genetic Alterations of Protein Tyrosine Phosphatases in Human Cancers
    Oncogene (2015) 34, 3885–3894 © 2015 Macmillan Publishers Limited All rights reserved 0950-9232/15 www.nature.com/onc REVIEW Genetic alterations of protein tyrosine phosphatases in human cancers S Zhao1,2,3, D Sedwick3,4 and Z Wang2,3 Protein tyrosine phosphatases (PTPs) are enzymes that remove phosphate from tyrosine residues in proteins. Recent whole-exome sequencing of human cancer genomes reveals that many PTPs are frequently mutated in a variety of cancers. Among these mutated PTPs, PTP receptor T (PTPRT) appears to be the most frequently mutated PTP in human cancers. Beside PTPN11, which functions as an oncogene in leukemia, genetic and functional studies indicate that most of mutant PTPs are tumor suppressor genes. Identification of the substrates and corresponding kinases of the mutant PTPs may provide novel therapeutic targets for cancers harboring these mutant PTPs. Oncogene (2015) 34, 3885–3894; doi:10.1038/onc.2014.326; published online 29 September 2014 INTRODUCTION tyrosine/threonine-specific phosphatases. (4) Class IV PTPs include Protein tyrosine phosphorylation has a critical role in virtually all four Drosophila Eya homologs (Eya1, Eya2, Eya3 and Eya4), which human cellular processes that are involved in oncogenesis.1 can dephosphorylate both tyrosine and serine residues. Protein tyrosine phosphorylation is coordinately regulated by protein tyrosine kinases (PTKs) and protein tyrosine phosphatases 1 THE THREE-DIMENSIONAL STRUCTURE AND CATALYTIC (PTPs). Although PTKs add phosphate to tyrosine residues in MECHANISM OF PTPS proteins, PTPs remove it. Many PTKs are well-documented oncogenes.1 Recent cancer genomic studies provided compelling The three-dimensional structures of the catalytic domains of evidence that many PTPs function as tumor suppressor genes, classical PTPs (RPTPs and non-RPTPs) are extremely well because a majority of PTP mutations that have been identified in conserved.5 Even the catalytic domain structures of the dual- human cancers are loss-of-function mutations.
    [Show full text]
  • Comprehensive Protein Tyrosine Phosphatase Mrna Profiling Identifies New Regulators in the Progression of Glioma Annika M
    Bourgonje et al. Acta Neuropathologica Communications (2016) 4:96 DOI 10.1186/s40478-016-0372-x RESEARCH Open Access Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma Annika M. Bourgonje1, Kiek Verrijp2, Jan T. G. Schepens1, Anna C. Navis2, Jolanda A. F. Piepers1, Chantal B. C. Palmen1, Monique van den Eijnden4, Rob Hooft van Huijsduijnen4, Pieter Wesseling2,3, William P. J. Leenders2 and Wiljan J. A. J. Hendriks1* Abstract The infiltrative behavior of diffuse gliomas severely reduces therapeutic potential of surgical resection and radiotherapy, and urges for the identification of new drug-targets affecting glioma growth and migration. To address the potential role of protein tyrosine phosphatases (PTPs), we performed mRNA expression profiling for 91 of the 109 known human PTP genes on a series of clinical diffuse glioma samples of different grades and compared our findings with in silico knowledge from REMBRANDT and TCGA databases. Overall PTP family expression levels appeared independent of characteristic genetic aberrations associated with lower grade or high grade gliomas. Notably, seven PTP genes (DUSP26, MTMR4, PTEN, PTPRM, PTPRN2, PTPRT and PTPRZ1) were differentially expressed between grade II-III gliomas and (grade IV) glioblastomas. For DUSP26, PTEN, PTPRM and PTPRT, lower expression levels correlated with poor prognosis, and overexpression of DUSP26 or PTPRT in E98 glioblastoma cells reduced tumorigenicity. Our study represents the first in-depth analysis of PTP family expression in diffuse glioma subtypes and warrants further investigations into PTP-dependent signaling events as new entry points for improved therapy. Keywords: Glioblastoma, Astrocytoma, EGFR, Oligodendroglioma, IDH1, DUSP26, MTMR4, PTEN, PTP, PTPRM, PTPRN2, PTPRT, PTPRZ1, Malignancy Introduction has slightly improved over the past decades, the prospect Gliomas arise from glial (precursor) cells and represent with current treatment is only a median 15 months fol- the most frequent type of primary brain tumor.
    [Show full text]